Protosthetics
Provides managed 3D printing solutions and central fabrication services for the orthotics and prosthetics industry.
- CEO / Founder
- Darren Jacoby
- Team Size
- 11-50
- Stage
- Active
- Total Funding
- $1.26M
- Latest Round
- Seed
- Key Investors
- Gener8tor; North Dakota Development Fund
Technology & Products
Key Products
Galileo program; Central fabrication services
Technological Advantage
FDA-registered facility specializing in 3D printed O&P; 'plug-and-play' integration for clinics without requiring internal design expertise.
Differentiation
Value Proposition
Enables O&P clinics to implement in-house 3D printing via a managed 'plug-and-play' model (Galileo) or outsource to an FDA-registered central fabrication facility, reducing turnaround times and improving device quality.
How They Differentiate
Focuses on clinical integration and managed design rather than just hardware sales; emphasizes O&P-specific workflows and FDA compliance.
Market & Competition
Target Customers
Orthotics and prosthetics (O&P) clinics
Industry Verticals
Medical
Competitors
The company operates in a competitive market with 197 active competitors.
Growth & Milestones
Growth Metrics
Over 100 clinics using the platform; Processed thousands of digital O&P orders
Major Milestones
Launched Galileo program; Started internal 3D printing in 2022; Established FDA-registered facility
Notable Customers
Miller Prosthetics & Orthotics; Floyd Brace Company; Louisville Prosthetics